|
May 9
|
3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy
|
|
May 9
|
Novo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss Blockbuster
|
|
May 9
|
Novo taps another Flagship startup in search for next obesity drugs
|
|
May 8
|
Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
|
|
May 7
|
13 Best Stocks That Will Always Grow
|
|
May 6
|
Trading in Novo Nordisk shares by board members, executives and associated persons
|
|
May 6
|
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
|
|
May 6
|
Investors Pile Into Amgen in Search of Next Obesity Drug Payout
|
|
May 6
|
Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
|
|
Mar 30
|
20 Countries with the Highest Age Dependency Ratio in the World
|
|
Mar 29
|
Ozempic Could Sell at a Profit for $57 a Year, Report Says. It’s Priced at $11,600.
|
|
Mar 29
|
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
|
|
Mar 28
|
2 Top Biotech Buyout Candidates
|
|
Mar 28
|
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
|
|
Mar 28
|
Insiders Are Dumping These 10 Healthcare Stocks
|
|
Mar 27
|
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
|
|
Mar 26
|
Viking Therapeutics stock rises on positive Phase 1 weight-loss pill data
|
|
Mar 26
|
Viking Therapeutics Posts Promising Early Weight-Loss Data as Cost Worries Escalate
|
|
Mar 26
|
Novo Nordisk (NVO) to Buy Cardior to Boost Heart Disease Pipeline
|
|
Mar 26
|
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
|